November 27, 2014 [October 31, 2023]
BPC-157, in particular, has demonstrated protective effects against NSAID-induced gastric damage and may act on nitric oxide pathways to maintain vascular homeostasis
and avoiding things that are harmful to your body, such as smoking, alcohol, coffee, soft drinks, junk food, and excess amounts of sugar
Common Contraindications Active or recent cancer (BPC-157 and TB-500 angiogenesis concern), Wilson's disease or other copper metabolism disorders (GHK-Cu component), pregnancy or breastfeeding (no safety data for any component), and competitive sport at WADA-tested levels (BPC-157 and TB-500 are listed under WADA category S0 Unapproved Substances) are commonly cited reasons not to research KLOW
This agrees with a previous study in sheep 9
Dihexas publication count is closer to compounds that never made it past early preclinical work